跳至主要内容
临床试验/NCT00892333
NCT00892333已完成不适用

Repair of Large Abdominal Hernia Defects By A Novel Biologic Mesh: A Prospective Multi-Center Observational Study

Integra LifeSciences Corporation8 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
8
主要终点
Hernia recurrence

研究概览

简要总结

The rate of hernia recurrence at one year following repair of a large abdominal hernia with a biologic mesh is high, ranging from 30% to 100%, with a reported historic average rate of 40%. The purpose of this study is to evaluate the rate of hernia recurrence at one year following repair with SurgiMend 3.0, an FDA-cleared novel biologic mesh, the hypothesis being that such rate will be less than 20% at one year, representing a 50% reduction over the historic rate of 40%.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All three of the following criteria must be present for enrollment into the study:
  • Large abdominal hernia
  • Inability to close the fascia primarily
  • Contra-indication for the use of synthetic mesh
  • Age > 18 years

排除标准

  • Use of SurgiMend 3.0 to simply reinforce a complete closure of the fascia performed either primarily or sequentially or by component separation technique
  • Inability to close the skin over the SurgiMend 3.0

结局指标

主要结局

Hernia recurrence

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Large Abdominal Hernia Repair With SurgiMend 3.0 | 临床试验